AGÕæÈ˹ٷ½

STOCK TITAN

Myriad Genetics Earns 2025 Great Place To Work Certification�

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Myriad Genetics (NASDAQ: MYGN) has achieved Great Place to Work Certification for the third consecutive year, with 84% of employees endorsing the company as a great workplace - surpassing the U.S. company average by 30 percentage points.

The certification, granted by Great Place To Work®, the global authority on workplace culture, recognizes Myriad's commitment to creating an inclusive and supportive work environment. The company's success is attributed to its focus on employee resource groups, community building, and ensuring teammates feel connected and empowered.

Myriad Genetics (NASDAQ: MYGN) ha ottenuto la certificazione Great Place to Work per il terzo anno consecutivo, con il 84% dei dipendenti che raccomandano l'azienda come un ottimo luogo di lavoro, superando la media delle aziende statunitensi di 30 punti percentuali.

La certificazione, rilasciata da Great Place To Work®, autorità globale nella cultura aziendale, riconosce l'impegno di Myriad nel creare un ambiente di lavoro inclusivo e di supporto. Il successo dell'azienda è dovuto al suo focus sui gruppi di risorse per i dipendenti, la costruzione di comunità e l'assicurare che i collaboratori si sentano connessi e valorizzati.

Myriad Genetics (NASDAQ: MYGN) ha obtenido la certificación Great Place to Work por tercer año consecutivo, con un 84% de los empleados que recomiendan la empresa como un excelente lugar para trabajar, superando en 30 puntos porcentuales el promedio de empresas en EE. UU.

La certificación, otorgada por Great Place To Work®, la autoridad global en cultura laboral, reconoce el compromiso de Myriad para crear un ambiente laboral inclusivo y de apoyo. El éxito de la empresa se atribuye a su enfoque en grupos de recursos para empleados, la construcción de comunidad y asegurar que los compañeros se sientan conectados y empoderados.

Myriad Genetics (NASDAQ: MYGN)µç� 3ë…� ì—°ì† Great Place to Work ì¸ì¦ì� 받았으며, ì§ì› 84%ê°€ 회사ë¥� 훌륭í•� ì§ìž¥ìœ¼ë¡œ 추천하여 미국 기업 í‰ê· ë³´ë‹¤ 30%í¬ì¸íŠ� 높게 나타났습니다.

ì� ì¸ì¦ì€ ì§ìž¥ 문화 분야ì� 세계ì � 권위ì� Great Place To Work®ì—서 수여í•� 것으ë¡�, Myriadê°€ í¬ìš©ì ì´ê³� ì§€ì›ì ì� 근무 환경ì� 조성하기 위해 노력í•� ì ì„ ì¸ì •합니ë‹�. 회사ì� ì„±ê³µì€ ì§ì› ìžì› 그룹, 커뮤니티 구축, 그리ê³� 팀ì›ë“¤ì� 소ì†ê°ì„ ëŠë¼ê³� 권한ì� 부여받ë„ë¡ í•˜µç” ë� 중ì ì� ë‘� ë� 있습니다.

Myriad Genetics (NASDAQ : MYGN) a obtenu la certification Great Place to Work pour la troisième année consécutive, avec 84 % des employés recommandant l’entreprise comme un excellent lieu de travail, dépassant la moyenne des entreprises américaines de 30 points de pourcentage.

Cette certification, délivrée par Great Place To Work®, l’autorité mondiale en matière de culture d’entreprise, reconnaît l’engagement de Myriad à créer un environnement de travail inclusif et bienveillant. Le succès de l’entreprise repose sur son attention portée aux groupes de ressources pour les employés, à la création de communauté et à l’assurance que les collaborateurs se sentent connectés et valorisés.

Myriad Genetics (NASDAQ: MYGN) hat zum dritten Mal in Folge die Great Place to Work-Zertifizierung erhalten, wobei 84 % der Mitarbeitenden das Unternehmen als großartigen Arbeitsplatz empfehlen � und damit den US-Unternehmensdurchschnitt um 30 Prozentpunkte übertreffen.

Die Zertifizierung, verliehen von Great Place To Work®, der globalen Autorität für Unternehmenskultur, würdigt Myriads Engagement für ein inklusives und unterstützendes Arbeitsumfeld. Der Erfolg des Unternehmens wird auf den Fokus auf Mitarbeiterressourcengruppen, Gemeinschaftsbildung und darauf zurückgeführt, dass sich Teammitglieder verbunden und gestärkt fühlen.

Positive
  • 84% employee satisfaction rate, 30 points above U.S. average
  • Achieved certification for third consecutive year
  • Strong employee resource groups and inclusive culture
Negative
  • None.

SALT LAKE CITY, July 15, 2025 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it has received the Great Place to Work Certification for the third year in a row. The certification is based entirely on what current employees say about their experience working at Myriad. This year, 84% of employees said Myriad Genetics is a Great Place To Work � 30 percentage points higher than the average U.S. company.

“Our focus on inclusivity and caring makes this a great place to work,� shared a current Myriad Genetics employee in the survey. “Our employee resource groups give employees a place to connect with employees like them, an opportunity to share their struggles and successes, and a community to support them.�

Great Place To Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation.

“At Myriad Genetics, our teammates are critical to achieving our shared mission of advancing health and well-being for all,� said Shereen Solaiman, chief people officer, Myriad Genetics. “We are honored to be recognized as a Great Place to Work for the third year in a row. This certification reflects the passion and dedication of our teammates, who are committed to building a workplace where every teammate feels connected, supported, and empowered to make a difference.�

"Great Place To Work Certification is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience," says Sarah Lewis-Kulin, the Vice President of Global Recognition at Great Place To Work. She emphasizes that Certification is the sole official recognition earned by the real-time feedback of employees regarding their company culture. “By successfully earning this recognition, it is evident that Myriad Genetics stands out as one of the top companies to work for, providing a great workplace environment for its employees."

to explore open roles and learn more about what it’s like to work at Myriad.

About Great Place to Work Certification�
Great Place To Work® Certification� is the most definitive “employer-of-choice� recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience � specifically, how consistently they experience a high-trust workplace. Great Place to Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place To Work-Certified.

About Great Place To Work®
As the global authority on workplace culture, Great Place To Work® brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Their proprietary platform and For All� Model helps companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified� or receiving recognition on a coveted Best Workplaces� List.

Learn more at and follow Great Place To Work on , , and .

About Myriad GeneticsÌý
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit .

Safe Harbor Statement
This press release contains “forward-looking statementsâ€� within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to Myriad’s commitment to building a workplace where every teammate feels connected, supported, and empowered to make a difference. These “forward-looking statementsâ€� are management’s expectations of future events as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially and adversely from those anticipated. Such factors include those risks described in the company’s filings with the U.S. Securities and Exchange Commission, including the company’s Annual Report on Form 10-K filed on February 28, 2025, as well as any updates to those risk factors filed from time to time in the company’s Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. Myriad is not under any obligation, and it expressly disclaims any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise except as required by law.Ìý

Investor ContactÌý
Matt ScaloÌý
(801) 584-3532Ìý
Ìý

Media ContactÌý
Kate Schraml
(224) 875-4493
ÌýÌý


FAQ

What percentage of Myriad Genetics employees rated it as a Great Place to Work in 2025?

84% of Myriad Genetics employees rated it as a Great Place to Work, which is 30 percentage points higher than the average U.S. company.

How many consecutive years has Myriad Genetics (MYGN) received the Great Place to Work certification?

Myriad Genetics has received the Great Place to Work certification for three consecutive years as of 2025.

What makes Myriad Genetics (MYGN) stand out as a workplace according to employees?

According to employees, Myriad Genetics stands out for its focus on inclusivity and caring, with employee resource groups providing connection, support, and community for workers.

Who is the Chief People Officer at Myriad Genetics in 2025?

Shereen Solaiman serves as the Chief People Officer at Myriad Genetics in 2025.
Myriad Genetics

NASDAQ:MYGN

MYGN Rankings

MYGN Latest News

MYGN Latest SEC Filings

MYGN Stock Data

360.41M
89.18M
2.77%
103.48%
8.2%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
United States
SALT LAKE CITY